Abiopharma

🔍 BLACKWOOD-KAPRAL LISA (Executive)

Company: Maplebear Inc. (CART)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 20,851 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 68,361.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 9,390 shares of Common Stock at $40.2454 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,971.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The shares represent restricted stock units (RSUs). 12.5% of the RSUs vest on the first quarterly anniversary of February 15, 2026, and the remainder of the RSUs vest in 7 equal quarterly installments thereafter, subject to continued service through each vesting date.
• F2: The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2025.
• F3: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.53 to $40.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.